Research view
Title: | Cognitive dysfunction in b-thalassemia major and intermedia patients and its clinical correlates |
Author: | Mahmoud M. Elhabiby, Walaa ElSalakawy, Sherien A. Khalil, Dina I. Hassan and Samer G. Hjislam |
Abstract: |
Background
In Egypt, thalassemia is considered one of the most common genetically determined
hemolytic diseases. Its high prevalence causes a significant burden on health
resources. Few studies conducted on thalassemia patients have shown a heightened
risk for cognitive function affection, and hence affects the patient’s quality of life.
Objective
The aim of this study was to assess the cognitive functions and its clinical correlates in
b-thalassemia major and b-thalassemia intermedia patients in comparison with healthy
controls.
Patients and methods
This study included 40 b-thalassemia patients who were divided into two groups: 20
b-thalassemia major patients and 20 b-thalassemia intermedia patients. 20 controls
matched for age and sex participated in the study. Cases were collected from the
Hematology Outpatient Clinic, Internal Medicine Department of Ain Shams University.
All participants were subjected to a full neuropsychological battery.
Results
Compared with controls, both b-thalassemia patient groups were equally and
significantly impaired on most of the neuropsychological battery domains. Serum
hemoglobin, serum iron, heart abnormalities, and liver functions were nonsignificant
correlates, and hepatitis C virus infection and vaccination history were significant
correlates.
Conclusion
Our findings suggest that both thalassemia types are equally affected as regards
multiple cognitive domains, with no correlation with blood transfusion or serum iron
levels, questioning any role for hemosiderosis as a cause for cognitive impairment.
|
Journal: | Middle East Current Psychiatry 2016, 23:128–133 |
Text: | |
Download |